Takeda Pharmaceutical Co Ltd
TSE:4502

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
TSE:4502
Watchlist
Price: 4 084 JPY 0.64% Market Closed
Market Cap: 6.5T JPY

Balance Sheet

Balance Sheet Decomposition
Takeda Pharmaceutical Co Ltd

Current Assets 2.5T
Cash & Short-Term Investments 405.6B
Receivables 725.3B
Other Current Assets 1.4T
Non-Current Assets 11.7T
Long-Term Investments 361.9B
PP&E 2T
Intangibles 9T
Other Non-Current Assets 441B

Balance Sheet
Takeda Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
437 916
278 488
243 324
462 890
188 640
335 027
389 058
229 557
457 800
385 113
Cash Equivalents
437 916
278 488
243 324
462 890
188 640
335 027
389 058
229 557
457 800
385 113
Short-Term Investments
122 110
97 650
131 862
262 929
464 796
667 793
485 942
324 147
267 700
20 476
Total Receivables
430 571
444 778
428 792
749 119
784 921
812 714
724 377
681 693
697 610
725 254
Accounts Receivables
376 490
356 453
360 833
657 681
670 708
707 487
617 517
575 430
612 439
709 465
Other Receivables
54 081
88 325
67 959
91 438
114 213
105 227
106 860
106 263
85 171
15 789
Inventory
254 010
226 048
212 944
919 670
759 599
753 881
853 167
986 457
1 209 869
1 217 349
Other Current Assets
129 180
213 452
61 886
598 429
271 476
143 478
141 098
176 102
178 212
173 000
Total Current Assets
1 373 787
1 260 416
1 078 808
2 993 037
2 469 432
2 712 893
2 593 642
2 397 956
2 558 580
2 521 192
PP&E Net
551 916
527 344
536 801
1 331 931
1 386 370
1 453 917
1 582 800
1 691 229
1 989 777
1 968 209
PP&E Gross
551 916
527 344
536 801
1 331 931
1 386 370
1 453 917
1 582 800
1 691 229
1 989 777
0
Accumulated Depreciation
671 923
607 089
654 597
639 591
697 754
737 818
870 208
1 007 754
1 220 701
0
Intangible Assets
743 128
1 063 037
1 014 264
4 751 169
4 171 361
3 909 106
3 818 544
4 269 657
4 274 682
3 631 560
Goodwill
779 316
1 019 574
1 029 248
4 240 251
4 012 528
4 033 917
4 407 749
4 790 723
5 410 067
5 324 430
Long-Term Investments
186 190
303 047
304 385
299 922
369 455
348 350
330 133
378 857
430 608
361 926
Other Long-Term Assets
189 748
173 376
142 957
176 463
411 948
454 110
445 150
429 328
445 078
441 027
Other Assets
779 316
1 019 574
1 029 248
4 240 251
4 012 528
4 033 917
4 407 749
4 790 723
5 410 067
5 324 430
Total Assets
3 824 085
N/A
4 346 794
+14%
4 106 463
-6%
13 792 773
+236%
12 821 094
-7%
12 912 293
+1%
13 178 018
+2%
13 957 750
+6%
15 108 792
+8%
14 248 344
-6%
Liabilities
Accounts Payable
135 205
125 713
133 705
212 348
211 627
232 105
295 933
307 453
319 955
475 541
Short-Term Debt
0
405 054
18
500 002
5 014
69
285
256
251
0
Current Portion of Long-Term Debt
228 464
139 974
0
484 944
581 803
22 084
203 708
339 344
367 000
548 939
Other Current Liabilities
493 544
695 605
603 786
1 355 755
1 377 454
1 518 918
1 645 804
1 834 887
1 625 897
1 482 041
Total Current Liabilities
857 213
1 366 346
737 509
2 553 049
2 175 898
1 773 176
2 145 730
2 481 940
2 313 103
2 506 521
Long-Term Debt
539 760
599 862
985 644
4 766 005
4 506 487
4 613 218
4 141 418
4 042 741
4 476 501
3 966 326
Deferred Income Tax
123 469
153 396
90 725
783 356
765 079
576 542
473 145
295 178
118 158
35 470
Minority Interest
62 511
54 704
19 985
4 006
4 003
4 140
504
549
741
895
Other Liabilities
292 440
278 225
275 176
504 372
646 144
772 180
734 202
783 219
927 025
804 048
Total Liabilities
1 875 393
N/A
2 452 533
+31%
2 109 039
-14%
8 610 788
+308%
8 097 611
-6%
7 739 256
-4%
7 494 999
-3%
7 603 627
+1%
7 835 528
+3%
7 313 260
-7%
Equity
Common Stock
64 766
65 203
77 914
1 643 585
1 668 123
1 668 145
1 676 263
1 676 345
1 676 596
1 694 685
Retained Earnings
1 523 127
1 511 817
1 557 307
1 595 431
1 369 972
1 509 906
1 479 716
1 541 146
1 391 203
1 187 586
Additional Paid In Capital
68 829
74 972
90 740
1 650 232
1 680 287
1 688 424
1 708 873
1 728 830
1 747 414
1 775 713
Unrealized Security Profit/Loss
0
67 980
73 037
46 380
22 891
41 983
22 068
12 470
15 729
0
Treasury Stock
0
48 734
74 373
57 142
87 463
59 552
116 007
100 317
51 259
74 815
Other Equity
269 421
223 023
272 799
303 499
69 673
324 131
912 106
1 495 649
2 493 581
2 351 915
Total Equity
1 948 692
N/A
1 894 261
-3%
1 997 424
+5%
5 181 985
+159%
4 723 483
-9%
5 173 037
+10%
5 683 019
+10%
6 354 123
+12%
7 273 264
+14%
6 935 084
-5%
Total Liabilities & Equity
3 824 085
N/A
4 346 794
+14%
4 106 463
-6%
13 792 773
+236%
12 821 094
-7%
12 912 293
+1%
13 178 018
+2%
13 957 750
+6%
15 108 792
+8%
14 248 344
-6%
Shares Outstanding
Common Shares Outstanding
784
781
781
1 555
1 558
1 563
1 550
1 555
1 569
1 574